EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Summary by AI ^BETAClose X

Dermapharm Holding SE has issued a preliminary announcement regarding the disclosure of its annual financial reports for the group. These reports will be made public on March 31, 2026, and will be available in both German and English on the company's investor relations website. This announcement serves to inform stakeholders of the upcoming release of detailed financial information.

Disclaimer*

EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements
Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

20.03.2026 / 11:07 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report of the group

Language: German
Date of disclosure: March 31, 2026
Address: https://ir.dermapharm.de/de/investor-relations/finanzberichte-praesentationen/

Language: English
Date of disclosure: March 31, 2026
Address: https://ir.dermapharm.de/en/investor-relations/financial-reports-presentations/

20.03.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News